Physician profile

Kyle T Stier

Physical Medicine & Rehabilitation · Princeton, NJ

NPI 1669406427

$450.83

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

See the full distribution for Physical Medicine & Rehabilitation

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$50.25

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Bioventus LLC $106.88 2020-2022
Ferring Pharmaceuticals INC. $104.59 2019-2024 Euflexxa
Pacira Therapeutics, INC. $70.50 2019
Depuy Synthes Sales INC. $48.55 2019-2020
Pfizer INC. $30.00 2019
Si-Bone, INC. $18.75 2021
Heraeus Medical, LLC. $16.34 2021
Vertical Pharmaceuticals, LLC $14.96 2019
Electronic Waveform Lab, INC. $14.85 2019
Sanofi-Aventis U.S. LLC $14.47 2019
Ermi LLC $10.94 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Kyle T Stier

$450.83

in general payments reported 2019-2025

Years
2019-2024
Top company
Bioventus LLC

https://glasscript.com/doctor/347835/kyle-t-stier

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.